Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines
被引:0
作者:
M. Gillard
论文数: 0引用数: 0
h-index: 0
机构:UCB S.A.,In Vitro Pharmacology Department, Chemin du Foriest
M. Gillard
M. Strolin Benedetti
论文数: 0引用数: 0
h-index: 0
机构:UCB S.A.,In Vitro Pharmacology Department, Chemin du Foriest
M. Strolin Benedetti
P. Chatelain
论文数: 0引用数: 0
h-index: 0
机构:UCB S.A.,In Vitro Pharmacology Department, Chemin du Foriest
P. Chatelain
E. Baltes
论文数: 0引用数: 0
h-index: 0
机构:UCB S.A.,In Vitro Pharmacology Department, Chemin du Foriest
E. Baltes
机构:
[1] UCB S.A.,In Vitro Pharmacology Department, Chemin du Foriest
[2] UCB S.A.,Non Clinical Department
[3] UCB S.A.,Non Clinical Department, Chemin du Foriest
来源:
Inflammation Research
|
2005年
/
54卷
关键词:
Plasma Concentration;
Histamine;
Drug Concentration;
Good Predictor;
Receptor Site;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
The predictive efficacy of drugs in humans is frequently estimated from both a high affinity for their receptor as measured in vitro and a long plasmatic half-life. This is grossly misleading since one key parameter is missing: drug concentration at the receptor site in vivo. As a case study we compared the efficacies of three H1 antihistamines in inhibiting histamine-induced wheal and flare in humans at two different time points with the above mentioned parameters. It is concluded that estimating in vivo receptor occupancy, which takes into account both the affinity of the drug for the receptor and its free plasma concentration, is a far better predictor for human pharmacodynamics and hence antihistamine potency, than considering in vitro affinity and plasmatic half-life only.